Marc D Beer
CIK 1314575 · Executive Chairman · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$377.9K
Companies
5
Total Filings
42
Lifetime Open-Market Net
-$9.71M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BTMD | Executive Chairman | 107,794 | $2.46 | $265.2K | $417.2K | 5 | 2026-06-10 |
| biote Corp. (BTMDW) Delisted | Director | 2,967,092 | $1.61 | $4.78M | -$2.60M | 5 | 2023-05-19 |
| NERV | Director | 25,000 | $4.51 | $112.8K | $405.8K | 7 | 2018-02-02 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Chief Executive Officer | 78,831 | — | — | -$7.94M | 22 | 2015-04-03 |
| VIACELL INC (VIAC) Delisted | President & CEO | 600,000 | $29.58 | $17.75M | $0 | 2 | 2007-11-08 |
Recent Filings · Page 2 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-31 | — | Mixed | +3,832,476 | $0 | |
| 2018-02-02 | NERV | Mixed | — | $0 | EDGAR |
| 2017-06-05 | NERV | Grant (A) | — | $0 | EDGAR |
| 2017-03-21 | NERV | Buy (P) | +50,000 | $405.8K | EDGAR |
| 2016-06-17 | NERV | Grant (A) | — | $0 | EDGAR |
| 2015-04-16 | NERV | Grant (A) | — | $0 | EDGAR |
| 2015-04-03 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-02-04 | NERV | Grant (A) | — | $0 | EDGAR |
| 2015-01-05 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-09-02 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Gift (G) | −769 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.